Clonal B cells of HCV‐associated mixed cryoglobulinemia patients contain exhausted marginal zone‐like and CD21low cells overexpressing Stra13

A clonal population of B cells expressing a VH1‐69‐encoded idiotype accumulates in hepatitis C virus (HCV) associated mixed cryoglobulinemia (MC). These cells are phenotypically heterogeneous, resembling either typical marginal zone (MZ) B cells (IgM+IgD+CD27+CD21+) or the exhausted CD21low B cells that accumulate in HIV infection or in common variable immunodeficiency. We show that both the MZ‐like and the CD21low VH1‐69+ B cells of MC patients are functionally exhausted, since they fail to respond to TLR and BCR ligands. The proliferative defect of VH1‐69+ B cells can be overcome by co‐stimulation of TLR9 and BCR in the presence of interleukin(IL)‐2 and IL‐10. The MZ‐like VH1‐69+ B cells do not express the inhibitory receptors distinctive of CD21low B cells, but display constitutive activation of extracellular signal regulated kinase (ERK) and attenuated BCR/ERK signaling. These cells also express abundant transcripts of Stra13 (DEC1, Bhlhb2, Sharp2, Clast5), a basic helix‐loop‐helix transcription factor that acts as a powerful negative regulator of B‐cell proliferation and homeostasis. Our findings suggest that MZ B cells activated by HCV undergo functional exhaustion associated with BCR signaling defects and overexpression of a key antiproliferative gene, and may subsequently become terminally spent CD21low B cells. Premature exhaustion may serve to prevent the outgrowth of chronically stimulated MZ B cells.

[1]  D. Klatzmann,et al.  Expansion of Functionally Anergic CD21−/low Marginal Zone-like B Cell Clones in Hepatitis C Virus Infection-Related Autoimmunity , 2011, The Journal of Immunology.

[2]  M. Carbonari,et al.  The VH1-69–expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21low phenotype , 2011, Blood.

[3]  T. Kawamoto,et al.  Basic helix‐loop‐helix transcription factor DEC1 negatively regulates cyclin D1 , 2011, The Journal of pathology.

[4]  T. Chun,et al.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. , 2011, The Journal of clinical investigation.

[5]  C. Rice,et al.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. , 2011, Blood.

[6]  K. Warnatz,et al.  Telomere‐dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency , 2011, European journal of immunology.

[7]  F. Marcucci,et al.  Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. , 2011, Blood.

[8]  T. Rothstein,et al.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.

[9]  C. Cunningham-Rundles,et al.  Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. , 2010, Blood.

[10]  T. Rothstein,et al.  Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. , 2009, Molecular immunology.

[11]  K. Schwarz,et al.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells , 2009, Proceedings of the National Academy of Sciences.

[12]  V. Sindhava,et al.  CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. , 2009, Molecular immunology.

[13]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[14]  O. Ohara,et al.  Discriminating gene expression profiles of memory B cell subpopulations , 2008, The Journal of experimental medicine.

[15]  G. Winslow,et al.  CD11c Expression Identifies a Population of Extrafollicular Antigen-Specific Splenic Plasmablasts Responsible for CD4 T-Independent Antibody Responses during Intracellular Bacterial Infection1 , 2008, The Journal of Immunology.

[16]  Nicholas W. Kin,et al.  DNA Microarray Gene Expression Profile of Marginal Zone versus Follicular B Cells and Idiotype Positive Marginal Zone B Cells before and after Immunization with Streptococcus pneumoniae1 , 2008, Journal of Immunology.

[17]  C. Rice,et al.  Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. , 2008, Blood.

[18]  C. Mecucci,et al.  Different genomic imbalances in low- and high-grade HCV-related lymphomas , 2008, Leukemia.

[19]  H. Aburatani,et al.  Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. , 2007, Cancer research.

[20]  Patrice Cacoub,et al.  The pathophysiology of HCV induced B-cell clonal disorders. , 2007, Autoimmunity reviews.

[21]  S. Gauld,et al.  B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.

[22]  A. Iolascon,et al.  Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. , 2006, Journal of hepatology.

[23]  O. Hermine,et al.  Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. , 2006, Blood.

[24]  S. Gauld,et al.  Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling , 2005, Nature Immunology.

[25]  M. Cooper,et al.  Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells , 2005, The Journal of experimental medicine.

[26]  B. Nilsson,et al.  Cryoglobulin‐induced cytokine production via FcγRIIa: inverse effects of complement blockade on the production of TNF‐α and IL‐10. Implications for the growth of malignant B‐cell clones , 2005, British journal of haematology.

[27]  M. Carbonari,et al.  Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1–69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis , 2005 .

[28]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[29]  Seiji Okada,et al.  Impaired lymphocyte development and function in Clast5/Stra13/DEC1‐transgenic mice , 2004, European journal of immunology.

[30]  H. Tsukamoto,et al.  Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. , 2004, Blood.

[31]  A. Lanzavecchia,et al.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. , 2003, Blood.

[32]  C. Goodnow,et al.  Resistance to CpG DNA–induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling , 2003, Nature Immunology.

[33]  Y. Wan,et al.  Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. , 2002, The Biochemical journal.

[34]  E. C. Snow,et al.  Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. , 2002, Molecular immunology.

[35]  S. Wong,et al.  Peritoneal CD5+ B-1 Cells Have Signaling Properties Similar to Tolerant B Cells* , 2002, The Journal of Biological Chemistry.

[36]  X. Mariette,et al.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. , 2002, The New England journal of medicine.

[37]  Seiji Okada,et al.  Clast5/Stra13 is a negative regulator of B lymphocyte activation. , 2002, Biochemical and biophysical research communications.

[38]  C. Mecucci,et al.  Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. , 2002, Blood.

[39]  S. Levy,et al.  The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. , 2001, Blood.

[40]  R. Flavell,et al.  Defective T cell activation and autoimmune disorder in Stra13-deficient mice , 2001, Nature Immunology.

[41]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[42]  S. Levy,et al.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. , 2001, Blood.

[43]  E. Jaffe,et al.  Cells of the marginal zone--origins, function and neoplasia. , 2001, Leukemia research.

[44]  A. Carbone,et al.  Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. , 2000, Blood.

[45]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.

[46]  Hong Sun,et al.  Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Capra,et al.  Molecular Characterization of the VH1‐Specific Variable Region Determinants Recognized by Anti‐Idiotypic Monoclonal Antibodies G6 and G8 , 1999, Scandinavian journal of immunology.